Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced MelanomaAntoni Ribas, Caroline Robert, Tara C. Gangadhar et al.|JAMA|2016Cited by 1.1k
Long-term efficacy of pembrolizumab (pembro; MK-3475) in a pooled analysis of 655 patients (pts) with advanced melanoma (MEL) enrolled in KEYNOTE-001.Adil Daud, Omid Hamid, Antoni Ribas et al.|Journal of Clinical Oncology|2015Cited by 89
P0116 Updated clinical efficacy of the anti-PD-1 monoclonal antibody pembrolizumab (MK-3475) in 411 patients with melanomaAntoni Ribas, F. Stephen Hodi, Jedd D. Wolchok et al.|European Journal of Cancer|2015Cited by 34
Pembrolizumab (Pembro; Mk-3475) for Advanced Melanoma (Mel): Randomized Comparison of Two Dosing SchedulesCaroline Robert, Omid Hamid, Anthony M. Joshua et al.|Annals of Oncology|2014Cited by 23
Model-based analysis of the relationship between pembrolizumab (MK-3475) exposure and efficacy in patients with advanced or metastatic melanoma.Richard W. Joseph, Richard Kefford, Tara C. Gangadhar et al.|Journal of Clinical Oncology|2015Cited by 6